Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
5.17
-0.06 (-1.15%)
At close: Apr 28, 2026, 4:00 PM EDT
5.15
-0.02 (-0.39%)
After-hours: Apr 28, 2026, 6:57 PM EDT
Intensity Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -11.61 | -16.27 | -10.54 | -7.58 | -7.9 | |
| Other Amortization | - | - | 0.16 | - | - | |
| Asset Writedown & Restructuring Costs | 0.03 | 0.03 | 0.15 | 0.18 | 0.17 | |
| Stock-Based Compensation | 2 | 3.12 | 1.4 | 1.17 | 0.72 | |
| Other Operating Activities | - | - | 2.26 | - | - | |
| Change in Accounts Payable | 0.36 | -2.27 | 1.63 | 0.7 | -0.05 | |
| Change in Other Net Operating Assets | -0.01 | 0.17 | -2.26 | 0.05 | 0.23 | |
| Operating Cash Flow | -9.23 | -15.22 | -7.21 | -5.48 | -6.83 | |
| Investment in Securities | - | 6.35 | -6.02 | - | - | |
| Investing Cash Flow | - | 6.35 | -6.02 | - | - | |
| Short-Term Debt Issued | - | - | 0.23 | 2.25 | 2 | |
| Total Debt Issued | - | - | 0.23 | 2.25 | 2 | |
| Net Debt Issued (Repaid) | - | - | 0.23 | 2.25 | 2 | |
| Issuance of Common Stock | 20.38 | 3.55 | 22.48 | - | 0.05 | |
| Other Financing Activities | -1.82 | -0.65 | -2.23 | - | - | |
| Financing Cash Flow | 18.56 | 2.9 | 20.47 | 2.25 | 2.05 | |
| Net Cash Flow | 9.33 | -5.97 | 7.24 | -3.23 | -4.78 | |
| Levered Free Cash Flow | -5.11 | -9.54 | -2.77 | -2.74 | -3.97 | |
| Unlevered Free Cash Flow | -5.11 | -9.54 | -2.74 | -2.69 | -3.97 | |
| Change in Working Capital | 0.35 | -2.1 | -0.63 | 0.76 | 0.18 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.